Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Coastlands Capital LP is named as a reporting person in SEC Form 4 filings. OQRO lists 7 transactions filed with the SEC under this name, the latest on Nov 10, 2026, each linked to the official Form 4.
Disclosures on record
7
Companies involved
3
Coastlands Capital LP bought shares on the open market in 2026 across 3 companies.
Coastlands Capital LP reported 7 open-market purchases and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $478K7×7 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
4 buys, median +18.4 pts vs S&P 500, beat it 3 of 4 times.
Average +14.3 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Jun 22, 2026 to Jul 17, 2026, measured from the first close after the filing. Past results, not a forecast.
Nov 9, 2026Bought~$319Kdisclosed Nov 10
DetailsOfficial recordAdial PharmaceuticalsADIL
5 disclosures · Jul 2026 · 5 bought
Jul 14, 2026Bought~$5.3Kdisclosed Jul 17
DetailsOfficial recordJul 16, 2026Bought~$3.4Kdisclosed Jul 17
DetailsOfficial recordJul 9, 2026Bought~$28Kdisclosed Jul 13
DetailsOfficial recordJul 10, 2026Bought~$4.6Kdisclosed Jul 13
DetailsOfficial recordJun 29, 2026Bought~$65Kdisclosed Jul 1
DetailsOfficial recordJun 17, 2026Bought~$53Kdisclosed Jun 22
DetailsOfficial recordAs of the latest filing on , Coastlands Capital LP reported holding 462,416 shares of Bolt Biotherapeutics (BOLT), worth about $2.81M at the last close of $6 (Nov 13, 2026), held through a coastlands capital lp. Holdings are also on file at Pasithea Therapeutics (KTTA), Adial Pharmaceuticals (ADIL); together they are worth about $6.77M. In the last 12 months, Coastlands Capital LP bought $478K in 7 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bolt Biotherapeutics BOLT | 462,416 | 462K coastlands capital lp | $6 | $2.81M | Nov 9, 2026 |
| Pasithea Therapeutics KTTA | 3,835,035 | 3.84M coastlands capital lp | $1 | $2M | Jun 17, 2026 |
| Adial Pharmaceuticals ADIL | 388,308 | 388K coastlands capital lp | $5 | $1.96M | Jul 16, 2026 |
Is this Coastlands Capital LP’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 9, 2026, Coastlands Capital LP reported holding 462,416 shares of Bolt Biotherapeutics (BOLT), held indirectly. At the last close of $6 on Nov 13, 2026, that is about $2.81M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Coastlands Capital LP reported 7 open-market purchases worth $478K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Coastlands Capital LP bought shares on the open market in 2026 across 3 companies.
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
3 companies: Adial Pharmaceuticals (ADIL, 2026), Pasithea Therapeutics (KTTA, 2026), Bolt Biotherapeutics (BOLT, 2026).
Coastlands Capital LP reported 5 open-market purchases and 0 sales here, 2026.
Coastlands Capital LP reported 1 open-market purchase and 0 sales here, 2026.
Coastlands Capital LP reported 1 open-market purchase and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
